Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban PK/PD in ESRD Patients on Hemodialysis
NCT00035178Phase 4Completed
- Sponsor
- Texas Biotechnology Inc.
- Start
- May 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of argatroban in end stage renal disease (ESRD) (3 arms), sponsored by Texas Biotechnology Inc. Primary endpoints: Activated Clotting Time, Safety and Tolerability and 1 more. Started May 2002; status: completed.
02
Drugs
argatroban
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT00035178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035178.